X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Valproate is a broad-spectrum antiepileptic and at the same time a mood stabiliser for bipolar disorder. It counts as particularly effective in certain seizure types, but it is subject to the strictest restrictions on use that exist in Germany for a medicine of this group: in girls and women of childbearing potential it may only be used under the conditions of a pregnancy prevention programme of its own. On top of that come regular checks of the liver values, the blood count and ammonia.
See more detail.gif)
A dosing reminder, your laboratory history and an interaction check in one place — free in the brite app.
| Property | Details |
|---|---|
| Active ingredient | Valproic acid, used also as sodium valproate or as a combination of both forms |
| ATC code | N03AG01 |
| Drug class | Broad-spectrum antiepileptic; at the same time a mood stabiliser used to prevent further episodes |
| Dosage forms | Prolonged-release tablets and prolonged-release granules, gastro-resistant tablets, an oral liquid, drops, solution for infusion |
| Half-life | In adults usually about 10 to 20 hours; shorter in children, longer where there is liver disease |
| Dosing | Started low, increased individually and adjusted to effect and tolerability; the maximum dose follows the SmPC, body weight and the indication |
| Onset of effect | Protection against seizures over days to weeks; the mood-stabilising effect takes longer |
| Breakdown | Predominantly in the liver; strongly bound to proteins in the blood — several interactions follow from that |
| Prescription status | Prescription-only medicine |
| Notable feature | A strict restriction on use in girls and women of childbearing potential: use only within the pregnancy prevention programme, with annual confirmation that the risks have been explained |
An epileptic seizure arises when nerve cells in the brain can no longer brake their activity sufficiently and fire together in a state of over-excitation. Valproate acts at several points at once to balance out this excess of excitation.¹
That same broad attack also explains the profile of side effects: tiredness, trembling and the effects on metabolism are no accident but the flip side of a drug that influences many systems at once.
Valproate has three fields of use, and they carry very different weight.
The details below describe the usual approach according to the SmPC. They are not a dosing instruction — the dose, the target range and any adjustments are set by the treating practice.¹
With antiepileptics, regularity is the best protection — brite reminds you reliably.
This is the most important section of the whole article. It is written factually, not alarmingly — but it leaves nothing out.
Valproate is the substance with the highest known risk to the unborn child among the antiepileptics in common use. The German Federal Institute for Drugs and Medical Devices (BfArM) has laid down mandatory educational material and a pregnancy prevention programme for it.³
Valproate is a substance with many interactions. Two properties explain almost all of them: it is strongly bound to proteins in the blood, and it influences the breakdown of other medicines in the liver.
| Combination | Consequence | What to do |
|---|---|---|
| Carbapenem antibiotics (e.g. meropenem, imipenem) | The valproate level falls drastically within a few days — a risk of seizures | The combination is avoided where possible; where it cannot be avoided, close monitoring of the level and of seizures in hospital |
| Lamotrigine | Valproate slows the breakdown, the lamotrigine level rises — a higher risk of severe skin reactions | The combination is established and often sensible, but it needs a markedly slower increase of the lamotrigine dose |
| Aspirin (acetylsalicylic acid) | Displaces valproate from its protein binding, so the freely active proportion rises; on top of that the effects on the platelets add up | Not for self-medication; discuss the choice of painkiller. Paracetamol is frequently the more straightforward option |
| Other antiepileptics that stimulate the liver's metabolism | The valproate level can fall, their own levels rise | Changes belong in specialist hands |
| Anticoagulants and platelet inhibitors | An increased tendency to bleed | Keep an eye on the blood count and clotting, raise it before procedures |
| Sedatives and sleeping tablets, antipsychotics | Increased tiredness and drowsiness | Combine only deliberately; reassess fitness to drive |
| Alcohol | More tiredness, a strain on the liver, a lower seizure threshold during withdrawal | Restraint, particularly with epilepsy |
The three points that matter most in practice, in plain words:
Because the list is long and not complete, it is worth a cross-check with every new preparation — including ones sold over the counter. The guide drug interactions and the interaction check in the brite app both help with that.
Valproate is accompanied by laboratory checks. What matters is to understand what each of the values can do — and what it cannot.
Unlike with some other substances, measuring the blood level of valproate is not a steering instrument for the dose. The laboratory records the total level, but only the proportion not bound to protein is active — and that proportion varies, for instance where the protein in the blood is low, in kidney disease, in older age or on aspirin.
So the rule is: what is treated is the person, not the laboratory value. The level is useful for checking whether the medicine is being taken as prescribed, for recognising interactions or for narrowing down an overdose. Whether the dose is right is decided by freedom from seizures, stability of mood and tolerability — see also understanding blood values.
Liver disease. In severe liver disease and in certain inherited metabolic disorders, valproate is not suitable; a family history of unexplained liver damage in childhood also belongs in the conversation beforehand. Where there is fatty liver, particular attention makes sense, because changes in the liver values are then harder to attribute. The general picture is set out in the guide medications for kidney and liver disease.
Small children. The risk of severe liver damage is highest in children under three years of age, particularly where several antiepileptics are used at the same time. Treatment here is therefore especially cautious and accompanied by close monitoring, see children and medications.
Older age. Older people react more sensitively to tiredness, unsteadiness of gait and confusion. The protein in the blood is often lower as well, so the active free proportion rises without the total level looking abnormal — see medications in old age and polypharmacy.
Alcohol. It puts an additional strain on the liver, adds to tiredness and lowers the seizure threshold during withdrawal — a subject that belongs in the open, without moralising, but with clear facts.
Stopping valproate abruptly can trigger severe seizures in epilepsy, up to status epilepticus — a prolonged seizure, which is an emergency. In bipolar disorder a sudden stop raises the risk of a rapid relapse.
Switching to another substance is not an exchange from one day to the next either: as a rule the new medicine is increased while the old one is slowly reduced — with a period of overlap. Where the switch is being made because you want a child, this planning ideally begins months in advance. For everyday life with a chronic condition, chronic illness in everyday life is also worth reading.
That does happen, particularly with treatments that were started many years ago. Today's requirements were only introduced step by step. What matters is not the look back but the next step: if you are a woman of childbearing potential and you take valproate, make an appointment specifically to review it. Two questions are at stake — whether a switch is possible and, if not, whether the conditions of the prevention programme are met. Both can be settled in one conversation. In the meantime, stop nothing.
Hair loss on valproate is usually diffuse, that is, spread over the whole head, and in many of those affected it recedes after a few months. Some report that regrowing hair is curlier or a different colour. There is no sound evidence that zinc or selenium preparations help. What does help is clearing up other causes: iron deficiency and thyroid disorders are common and are easily overlooked under the heading "it's the medicine".
Weight gain on valproate has several components: an increased appetite, changes in metabolism and sometimes water retention. The honest answer is that this cannot always be solved by discipline alone — and that it is nevertheless worth countering it early rather than later. If the gain is marked, or if it is making you think about stopping, it belongs on the table: there are alternatives, and the decision should be taken together, not in secret.
Yes, that is part of a procedure laid down by the authorities and not a piece of red tape invented by the practice. The point of it: information about risks fades with time, and life situations change — a woman for whom having a child was not on the cards five years ago may be planning differently today. The annual conversation is the moment when exactly that is looked at again. Use it actively and bring your questions with you.
The interaction check shows critical combinations before you take them.
A dosing reminder, your laboratory history and an interaction check in one place. Free.
Create medication plan